Clinical Trial Update: Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous bone marrow-derived stem cell transplantation for retinitis pigmentosa has completed. Sponsored by the University of Sao Pau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Autologous Bone Marrow-Derived Stem Cell Transplant (bone marrow-derived stem cell transplantation)

Snippet

Sponsor: University of Sao Paulo | Conditions: Retinitis Pigmentosa | Phase 2 | Status: COMPLETED